DESIGN OF PHASE‐I TRIALS OF IMMUNOPOTENTIATORS FOR CANCER THERAPY: LEVAMISOLE AND CORYNEBACTERIUM PARVUM*

Abstract
No abstract available

This publication has 0 references indexed in Scilit: